Benjamin Edwards’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$310K Buy
847
+61
+8% +$20.9K ﹤0.01% 1247
2026
Q2
$224K Buy
786
+8
+1% +$2.36K ﹤0.01% 1338
2026
Q1
$231K Buy
778
+88
+13% +$28.5K ﹤0.01% 1266
2025
Q4
$210K Buy
690
+51
+8% +$16.7K ﹤0.01% 1252
2025
Q3
$218K Buy
+639
New +$194K ﹤0.01% 1220

Other funds holding ONC

Benjamin Edwards's ONC Position: Q3 2026 in Review

Benjamin Edwards increased its BeOne Medicines Ltd (ONC) stake by 7.8% in Q3 2026, buying an estimated $20.9K and bringing the position to 847 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Benjamin Edwards first reported a position in ONC in Q3 2025 and has held it in 5 quarters since. 260 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Benjamin Edwards held 847 shares of BeOne Medicines Ltd worth $310K as of Q3 2026.
  • Benjamin Edwards bought 61 BeOne Medicines Ltd shares in Q3 2026, an estimated $20.9K.
  • BeOne Medicines Ltd made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1247 holding.
  • Benjamin Edwards first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 5 quarters since.
  • 260 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.